Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

708

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

BI 10773

Empagliflozin active

DRUG

BI 10773 Placebo

Empagliflozin placebo

DRUG

BI 10773 / BI 1356

Empagliflozin / Linagliptin 25/5 mg Dose FDC active

DRUG

BI 10773

Empagliflozin active

DRUG

BI 10773 / BI 1356

Empagliflozin / Linagliptin 10/5 mg Dose FDC active

DRUG

BI 10773 / BI 1356 Placebo

Empagliflozin / Linagliptin 10/5 mg Dose placebo FDC

DRUG

BI 10773

Empagliflozin active

DRUG

BI 10773

Empagliflozin active

DRUG

BI 10773

Empagliflozin active

DRUG

BI 10773 / BI 1356 Placebo

Empagliflozin / Linagliptin 25/5 mg Dose FDC placebo

DRUG

BI 10773 Placebo

Empagliflozin placebo

DRUG

BI 10773 / BI 1356 Placebo

Empagliflozin / Linagliptin 10/5 mg Dose FDC placebo

DRUG

BI 10773

Empagliflozin active

DRUG

BI 10773 / BI 1356 Placebo

Empagliflozin / Linagliptin 25/5 mg Dose FDC placebo

Trial Locations (114)

Unknown

1275.10.01019 Boehringer Ingelheim Investigational Site, Chino

1275.10.01008 Boehringer Ingelheim Investigational Site, Huntington Beach

1275.10.01003 Boehringer Ingelheim Investigational Site, San Diego

1275.10.01024 Boehringer Ingelheim Investigational Site, San Diego

1275.10.01002 Boehringer Ingelheim Investigational Site, Sylmar

1275.10.01011 Boehringer Ingelheim Investigational Site, Miami

1275.10.01009 Boehringer Ingelheim Investigational Site, Orlando

1275.10.01023 Boehringer Ingelheim Investigational Site, Oviedo

1275.10.01006 Boehringer Ingelheim Investigational Site, Tamarac

1275.10.01017 Boehringer Ingelheim Investigational Site, Conyers

1275.10.01016 Boehringer Ingelheim Investigational Site, Snellville

1275.10.01012 Boehringer Ingelheim Investigational Site, Avon

1275.10.01013 Boehringer Ingelheim Investigational Site, Muncie

1275.10.01010 Boehringer Ingelheim Investigational Site, Elkton

1275.10.01001 Boehringer Ingelheim Investigational Site, Stevensville

1275.10.01007 Boehringer Ingelheim Investigational Site, Salisbury

1275.10.01005 Boehringer Ingelheim Investigational Site, Bismarck

1275.10.01020 Boehringer Ingelheim Investigational Site, Oklahoma City

1275.10.01022 Boehringer Ingelheim Investigational Site, Pittsburgh

1275.10.01021 Boehringer Ingelheim Investigational Site, Union

1275.10.01014 Boehringer Ingelheim Investigational Site, North Richland Hills

1275.10.01018 Boehringer Ingelheim Investigational Site, Draper

1275.10.01015 Boehringer Ingelheim Investigational Site, Richmond

1275.10.01025 Boehringer Ingelheim Investigational Site, Virginia Beach

1275.10.54005 Boehringer Ingelheim Investigational Site, Caba

1275.10.54012 Boehringer Ingelheim Investigational Site, Caba

1275.10.54002 Boehringer Ingelheim Investigational Site, Capital Federal

1275.10.54007 Boehringer Ingelheim Investigational Site, Capital Federal

1275.10.54013 Boehringer Ingelheim Investigational Site, Capital Federal

1275.10.54006 Boehringer Ingelheim Investigational Site, Córdoba

1275.10.54008 Boehringer Ingelheim Investigational Site, Córdoba

1275.10.54011 Boehringer Ingelheim Investigational Site, Córdoba

1275.10.54003 Boehringer Ingelheim Investigational Site, Godoy Cruz, Mendoza

1275.10.54009 Boehringer Ingelheim Investigational Site, Mar del Plata

1275.10.54004 Boehringer Ingelheim Investigational Site, Salta

1275.10.54001 Boehringer Ingelheim Investigational Site, San Isidro

1275.10.54010 Boehringer Ingelheim Investigational Site, Zárate

1275.10.61008 Boehringer Ingelheim Investigational Site, Cardiff

1275.10.61002 Boehringer Ingelheim Investigational Site, East Ringwood

1275.10.61001 Boehringer Ingelheim Investigational Site, Heidelberg Heights

1275.10.61009 Boehringer Ingelheim Investigational Site, Mirrabooka

1275.10.02004 Boehringer Ingelheim Investigational Site, Edmonton

1275.10.02001 Boehringer Ingelheim Investigational Site, Red Deer

1275.10.02003 Boehringer Ingelheim Investigational Site, Chilliwack

1275.10.02009 Boehringer Ingelheim Investigational Site, Coquitlam

1275.10.02012 Boehringer Ingelheim Investigational Site, Vancouver

1275.10.02006 Boehringer Ingelheim Investigational Site, Winnipeg

1275.10.02008 Boehringer Ingelheim Investigational Site, Winnipeg

1275.10.02005 Boehringer Ingelheim Investigational Site, Moncton

1275.10.02013 Boehringer Ingelheim Investigational Site, Burlington

1275.10.02007 Boehringer Ingelheim Investigational Site, Greater Sudbury

1275.10.02002 Boehringer Ingelheim Investigational Site, Strathroy

1275.10.02011 Boehringer Ingelheim Investigational Site, Drummondville

1275.10.02010 Boehringer Ingelheim Investigational Site, Montreal

1275.10.34014 Boehringer Ingelheim Investigational Site, Ávila

1275.10.49007 Boehringer Ingelheim Investigational Site, Aßlar

1275.10.49014 Boehringer Ingelheim Investigational Site, Berlin

1275.10.49004 Boehringer Ingelheim Investigational Site, Cologne

1275.10.49016 Boehringer Ingelheim Investigational Site, Elsterwerda

1275.10.49012 Boehringer Ingelheim Investigational Site, Hamburg

1275.10.49005 Boehringer Ingelheim Investigational Site, Hatten

1275.10.49008 Boehringer Ingelheim Investigational Site, Kiel Kronshagen

1275.10.49010 Boehringer Ingelheim Investigational Site, Lübeck

1275.10.49003 Boehringer Ingelheim Investigational Site, Münster

1275.10.49006 Boehringer Ingelheim Investigational Site, Pirna

1275.10.49013 Boehringer Ingelheim Investigational Site, Saint Ingbert/Oberwürzbach

1275.10.49001 Boehringer Ingelheim Investigational Site, Unterschneidheim

1275.10.49015 Boehringer Ingelheim Investigational Site, Wangen

1275.10.39005 Boehringer Ingelheim Investigational Site, Ancona

1275.10.39006 Boehringer Ingelheim Investigational Site, Catania

1275.10.39009 Boehringer Ingelheim Investigational Site, Catania

1275.10.39014 Boehringer Ingelheim Investigational Site, Catania

1275.10.39007 Boehringer Ingelheim Investigational Site, Latina

1275.10.39012 Boehringer Ingelheim Investigational Site, Milan

1275.10.39013 Boehringer Ingelheim Investigational Site, Milan

1275.10.39015 Boehringer Ingelheim Investigational Site, Olbia (OT)

1275.10.39016 Boehringer Ingelheim Investigational Site, Orbassano (TO)

1275.10.39004 Boehringer Ingelheim Investigational Site, Palermo

1275.10.39003 Boehringer Ingelheim Investigational Site, Pistoia

1275.10.39008 Boehringer Ingelheim Investigational Site, Roma

1275.10.39001 Boehringer Ingelheim Investigational Site, Sesto San Giovanni (MI)

1275.10.39010 Boehringer Ingelheim Investigational Site, Siena

1275.10.39011 Boehringer Ingelheim Investigational Site, Terni

1275.10.35104 Boehringer Ingelheim Investigational Site, Cantanhede

1275.10.35112 Boehringer Ingelheim Investigational Site, Porto

1275.10.35103 Boehringer Ingelheim Investigational Site, Sandim

1275.10.35105 Boehringer Ingelheim Investigational Site, Tornada

1275.10.35108 Boehringer Ingelheim Investigational Site, Valadares

1275.10.35101 Boehringer Ingelheim Investigational Site, Vila Nova de Gaia

1275.10.07004 Boehringer Ingelheim Investigational Site, Chelyabinsk

1275.10.07003 Boehringer Ingelheim Investigational Site, Saint Petersburg

1275.10.07006 Boehringer Ingelheim Investigational Site, Saint Petersburg

1275.10.07001 Boehringer Ingelheim Investigational Site, Saratov

1275.10.07005 Boehringer Ingelheim Investigational Site, Saratov

1275.10.07002 Boehringer Ingelheim Investigational Site, Yaroslavl

1275.10.34003 Boehringer Ingelheim Investigational Site, Barcelona

1275.10.34004 Boehringer Ingelheim Investigational Site, Canet de Mar

1275.10.34008 Boehringer Ingelheim Investigational Site, Centelles

1275.10.34009 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat (Barcelona)

1275.10.34012 Boehringer Ingelheim Investigational Site, La Roca del Vallès

1275.10.34006 Boehringer Ingelheim Investigational Site, Madrid

1275.10.34011 Boehringer Ingelheim Investigational Site, Mataró

1275.10.34001 Boehringer Ingelheim Investigational Site, Málaga

1275.10.34010 Boehringer Ingelheim Investigational Site, Málaga

1275.10.34013 Boehringer Ingelheim Investigational Site, Pineda de Mar

1275.10.34002 Boehringer Ingelheim Investigational Site, Sabadell

1275.10.34005 Boehringer Ingelheim Investigational Site, Tarragona

1275.10.38006 Boehringer Ingelheim Investigational Site, Chernivtsi

1275.10.38007 Boehringer Ingelheim Investigational Site, Dnipro

1275.10.38002 Boehringer Ingelheim Investigational Site, Kiev

1275.10.38003 Boehringer Ingelheim Investigational Site, Kiev

1275.10.38004 Boehringer Ingelheim Investigational Site, Lviv

1275.10.38001 Boehringer Ingelheim Investigational Site, Vinnitsa

1275.10.38005 Boehringer Ingelheim Investigational Site, Zhytomyr

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY